Liquid Biopsy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Liquid Biopsy Market: Product Type (Consumables, Instruments) Application Type (Blood, Urine Others) Sample Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer Others) End User (Hospitals, Diagnostic Laboratories, Academic and Research Centers Others) and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare

Description
Table Of Content
Company Profile

Report

Description

Liquid Biopsy Market size was valued at USD 4.4 in 2022 and is expected grow at a CAGR of 18.2% from 2022-2028. The market is gaining traction in recent times owing to its accurate, effective results in comparison with traditional cancer screening methods, which are achieved through minimal invasiveness and expenses. Challenges associated with traditional biopsies such as invasiveness, ill-informed results, post-sampling medical challenges and costs are prompting the healthcare professionals to adopt less invasive liquid biopsy tests for cancer screening and management, which is projected to create significant market demand for liquid biopsy products and services over the forecast period. Moreover, several clinical research activities related to biomarkers are in late stage and it is expected that upon successful launch and commercialization of these tests over the forecast period will result in significant market growth. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, This report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed liquid biopsy market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Liquid Biopsy Market

MARKET SUMMARY

18.2%

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 18.2%
Largest Market– North America
Fastest Growing Market– Asia-Pacific

Liquid Biopsy Market

The report on global liquid biopsy market gives historical, current and future market sizes (US$ Mn) based on the basis of product & services type, biomarker type, sample type, application, analysis method, end-user and geographic regions.
liquid biopsy market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in manufacturing, supply, and usage of liquid biopsy products and services.

Key Players

Biocept
Bio-Rad Laboratories
Fraunhofer-Gesellschaft
Guardant Health
Janssen Diagnostics, LLC

Liquid Biopsy Market

Drivers And Restraints

Players in the global liquid biopsy market increasingly attracting the investments in recent times for development and commercialization of late-stage products through IPOs. For instance, RainDance Technologies and Biocept filled IPOs in 2015 and 2014 respectively to develop advanced liquid biopsy technologies to aid physicians to devise suitable treatment strategies. Moreover, growing awareness among key stakeholders regarding liquid biopsy assays expected to drive market demand for these tests over the forecast period across the globe.

North-America got significant share

Liquid Biopsy Market

North America market expected to hold the higher revenue share in global liquid biopsy market and projected to remain same over the forecast period owing to accessibility, availability of advanced diagnostic tools such as liquid biopsy in the region. Asia-pacific liquid biopsy market projected to grow at significant CAGR over the forecast period in comparison with other regions owing to large medical unmet need in the region.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2017 – 2022) and forecast (2023 – 2029)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Liquid Biopsy Market Segmentation

By Product Type

Instruments
Reagents
Services and Software

By Sample

Blood Samples
Urine Samples
Other Biofluid Samples

By Application

Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Leukemia
Lung Cancer
Prostate Cancer
Other Cancers

By End User

Hospitals
Diagnostic Laboratories
Academic and Research Institutes

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

1. Executive summary

2. Global Liquid Biopsy Market Introduction

2.1. Global Liquid Biopsy Market – Taxonomy

2.2. Global Liquid Biopsy Market –Definitions

2.2.1. By Product Type

2.2.2. By Application Type

2.2.3. By Sample Type

2.2.4. By End User

3. Global Liquid Biopsy Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Liquid Biopsy Market Dynamics – Factors Impact Analysis

3.6. Global Liquid Biopsy Market – Regulations

3.6.1. U.S.

3.6.2. Europe

3.7. Federal Grants for Liquid Biopsy Startups

3.8. Venture Capital Investments in Liquid Biopsy Companies

3.9. Product Innovations

3.10. Startups working in the Liquid Biopsy

3.11. Novel Applications of Liquid Biopsy

4. Global Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Liquid Biopsy Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028

5.1. Consumables

5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Instruments

5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

6. Global Liquid Biopsy Market, By Sample Type, 2017 – 2021 and Forecast, 2022 – 2028

6.1. Blood

6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Urine

6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3. Others

6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7. Global Liquid Biopsy Market Forecast, By Application Type, 2017 – 2021 and Forecast, 2022 – 2028

7.1. Lung Cancer

7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Breast Cancer

7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Colorectal Cancer

7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Prostate Cancer

7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Liver Cancer

7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Others

7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.6.3. Market Opportunity Analysis

8. Global Liquid Biopsy Market Forecast, By End User Type, 2017 – 2021 and Forecast, 2022 – 2028

8.1. Hospitals

8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Diagnostic Laboratories

8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Academic and Research Centers

8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Others

8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

9. Global Liquid Biopsy Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028

9.1. North America

9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, Sample Type, End User, and Region, 2022 – 2028

10. North America Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

10.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Consumables

10.1.2. Instruments

10.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Blood

10.2.2. Urine

10.2.3. Others

10.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Lung Cancer

10.3.2. Breast Cancer

10.3.3. Colorectal Cancer

10.3.4. Prostate Cancer

10.3.5. Liver Cancer

10.3.6. Others

10.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Hospitals

10.4.2. Diagnostic Laboratories

10.4.3. Academic and Research Centers

10.4.4. Others

10.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. U.S.

10.5.2. Canada

10.6. North America Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028

10.7. North America Liquid Biopsy Market Dynamics – Trends

11. Europe Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

11.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Consumables

11.1.2. Instruments

11.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Blood

11.2.2. Urine

11.2.3. Others

11.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Lung Cancer

11.3.2. Breast Cancer

11.3.3. Colorectal Cancer

11.3.4. Prostate Cancer

11.3.5. Liver Cancer

11.3.6. Others

11.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. Hospitals

11.4.2. Diagnostic Laboratories

11.4.3. Academic and Research Centers

11.4.4. Others

11.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Poland

11.5.8. Holland

11.5.9. Rest of Europe

11.6. Europe Liquid Biopsy Market – Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028

11.7. Europe Liquid Biopsy Market Dynamics – Trends

12. Asia-Pacific Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

12.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Consumables

12.1.2. Instruments

12.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Blood

12.2.2. Urine

12.2.3. Others

12.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Lung Cancer

12.3.2. Breast Cancer

12.3.3. Colorectal Cancer

12.3.4. Prostate Cancer

12.3.5. Liver Cancer

12.3.6. Others

12.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Hospitals

12.4.2. Diagnostic Laboratories

12.4.3. Academic and Research Centers

12.4.4. Others

12.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028

12.7. Asia-Pacific Liquid Biopsy Market Dynamics – Trends

13. Latin America Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

13.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Consumables

13.1.2. Instruments

13.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Blood

13.2.2. Urine

13.2.3. Others

13.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Lung Cancer

13.3.2. Breast Cancer

13.3.3. Colorectal Cancer

13.3.4. Prostate Cancer

13.3.5. Liver Cancer

13.3.6. Others

13.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. Hospitals

13.4.2. Diagnostic Laboratories

13.4.3. Academic and Research Centers

13.4.4. Others

13.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Argentina

13.5.4. Venezuela

13.5.5. Rest of Latin America

13.6. Latin America Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028

13.7. Latin America Liquid Biopsy Market Dynamics – Trends

14. Middle East and Africa Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

14.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Consumables

14.1.2. Instruments

14.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.2.1. Blood

14.2.2. Urine

14.2.3. Others

14.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Lung Cancer

14.3.2. Breast Cancer

14.3.3. Colorectal Cancer

14.3.4. Prostate Cancer

14.3.5. Liver Cancer

14.3.6. Others

14.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.4.1. Hospitals

14.4.2. Diagnostic Laboratories

14.4.3. Academic and Research Centers

14.4.4. Others

14.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. Israel

14.5.3. South Africa

14.5.4. Rest of MEA

14.6. MEA Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028

14.7. MEA Liquid Biopsy Market Dynamics – Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Catabasis Pharmaceuticals Inc.

15.2.2. NS Pharma, Inc

15.2.3. Marathon Pharmaceuticals, LLC

15.2.4. ITALFARMACO S.p.A.

15.2.5. FibroGen, Inc.

15.2.6. Summit Therapeutics plc

15.2.7. PTC Therapeutics

15.2.8. Santhera Pharmaceuticals

15.2.9. Sarepta Therapeutics, Inc.

16. Research Methodology

17. Key Assumptions and Acronyms

Description

search

Liquid Biopsy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Liquid Biopsy Market

Drivers And Restraints

Liquid Biopsy Market

Features of the Report

By Product Type

By Sample

By Application

By End User

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE